Woodline Partners LP Kura Oncology, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 172,704 shares of KURA stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
172,704
Previous 143,207
20.6%
Holding current value
$1.42 Million
Previous $2.8 Million
46.25%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding KURA
# of Institutions
193Shares Held
77.5MCall Options Held
103KPut Options Held
106K-
Black Rock Inc. New York, NY6.97MShares$57.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$47.9 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$41.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.7 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $552M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...